KFF research shows that most Americans rely on prescription drugs but view their costs as excessively high. Many struggle with affordability, particularly minorities and the uninsured. While public support exists for Medicare price negotiations under the 2022 Inflation Reduction Act (IRA), awareness of its provisions remains low. Majorities back further regulatory actions to limit drug prices. Click here for article.
82% believe prescription drug prices are too high, blaming pharmaceutical profits.
30% of adults skip medication due to cost; more common among minorities and low-income groups.
55% are worried about affording prescriptions; concern is higher among the uninsured.
Awareness of IRA drug pricing provisions remains low, despite support for Medicare price negotiations.
Commenti